HomeAI · summaries
Storia in 4 fonti
People taking GLP-1 weight loss drugs like Ozempic started moving less
People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data found that daily step counts and exercise levels dropped after people started these medications, despite successful weight loss. Because the drugs can reduce muscle mass along with fat, the decline in physical activity raises concerns about preserving strength and long-term health.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
hindustantimes.com
Less stress, addiction, brain fog: Ozempic, GLP-1 drugs may be impacting patients' brain, neural networks
GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News
- ·
iol.co.za
The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects
From dramatic weight loss to dangerous side effects and fake Ozempic scams, here’s the truth about the GLP-1 craze gripping South Africa and Hollywood.
- ·
sciencedaily.com
People taking GLP-1 weight loss drugs like Ozempic started moving less
People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data…
- ·
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…
- ·
Scientists discover why ozempic may not work for some people
Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these…
- ·
independent.co.uk
Women on GLP-1 drugs 30 percent less likely to develop breast cancer
About 42,140 women are expected to die from breast cancer in the U.S. this year